158 related articles for article (PubMed ID: 26629935)
1. Suppression of Cellular Proliferation and Invasion by HMGB1 Knockdown in Bladder Urothelial Carcinoma Cells.
Liao H; Xiao Y; Hu Y; Xiao Y; Yin Z; Liu L
Oncol Res; 2014; 22(5-6):235-45. PubMed ID: 26629935
[TBL] [Abstract][Full Text] [Related]
2. Down-regulation of HMGB1 expression by shRNA constructs inhibits the bioactivity of urothelial carcinoma cell lines via the NF-κB pathway.
Huang Z; Zhong Z; Zhang L; Wang X; Xu R; Zhu L; Wang Z; Hu S; Zhao X
Sci Rep; 2015 Aug; 5():12807. PubMed ID: 26239046
[TBL] [Abstract][Full Text] [Related]
3. α4 contributes to bladder urothelial carcinoma cell invasion and/or metastasis via regulation of E-cadherin and is a predictor of outcome in bladder urothelial carcinoma patients.
Liu J; Cai M; Chen J; Liao Y; Mai S; Li Y; Huang X; Liu Y; Zhang J; Kung H; Zeng Y; Zhou F; Xie D
Eur J Cancer; 2014 Mar; 50(4):840-51. PubMed ID: 24388773
[TBL] [Abstract][Full Text] [Related]
4. The ERH gene regulates migration and invasion in 5637 and T24 bladder cancer cells.
Pang K; Zhang Z; Hao L; Shi Z; Chen B; Zang G; Dong Y; Li R; Liu Y; Wang J; Zhang J; Cai L; Han X; Han C
BMC Cancer; 2019 Mar; 19(1):225. PubMed ID: 30866868
[TBL] [Abstract][Full Text] [Related]
5. The adenosine A2b receptor promotes tumor progression of bladder urothelial carcinoma by enhancing MAPK signaling pathway.
Zhou Y; Chu X; Deng F; Tong L; Tong G; Yi Y; Liu J; Tang J; Tang Y; Xia Y; Dai Y
Oncotarget; 2017 Jul; 8(30):48755-48768. PubMed ID: 28548944
[TBL] [Abstract][Full Text] [Related]
6. Targeting MACC1 by RNA interference inhibits proliferation and invasion of bladder urothelial carcinoma in T24 cells.
Xu ST; Ding X; Ni QF; Jin SJ
Int J Clin Exp Pathol; 2015; 8(7):7937-44. PubMed ID: 26339359
[TBL] [Abstract][Full Text] [Related]
7. Solute carrier family 12 member 5 promotes tumor invasion/metastasis of bladder urothelial carcinoma by enhancing NF-κB/MMP-7 signaling pathway.
Liu JY; Dai YB; Li X; Cao K; Xie D; Tong ZT; Long Z; Xiao H; Chen MK; Ye YL; Liu B; Tan J; Tang J; Xu ZZ; Gan Y; Zhou YH; Deng F; He LY
Cell Death Dis; 2017 Mar; 8(3):e2691. PubMed ID: 28333147
[TBL] [Abstract][Full Text] [Related]
8. Overexpression and clinicopathological contribution of DcR3 in bladder urothelial carcinoma tissues.
Jiang YQ; Zhong TF; Dang YW; Zou LS; Yang L; Yang X; Chen G
Asian Pac J Cancer Prev; 2014; 15(21):9137-42. PubMed ID: 25422191
[TBL] [Abstract][Full Text] [Related]
9. T-cell immunoglobulin mucin-3 expression in bladder urothelial carcinoma: Clinicopathologic correlations and association with survival.
Yang M; Yu Q; Liu J; Fu W; Cao Y; Yu L; Shao S; Wang X; Niu H; Wang Y
J Surg Oncol; 2015 Sep; 112(4):430-5. PubMed ID: 26265374
[TBL] [Abstract][Full Text] [Related]
10. Repression of engrailed 2 inhibits the proliferation and invasion of human bladder cancer in vitro and in vivo.
Li Y; Liu H; Lai C; Su Z; Heng B; Gao S
Oncol Rep; 2015 May; 33(5):2319-30. PubMed ID: 25812440
[TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA
Wu D; Zhang T; Wang J; Zhou J; Pan H; Qu P
Aging (Albany NY); 2019 Dec; 11(24):12624-12640. PubMed ID: 31848324
[TBL] [Abstract][Full Text] [Related]
12. Inhibition of REDD1 Sensitizes Bladder Urothelial Carcinoma to Paclitaxel by Inhibiting Autophagy.
Zeng Q; Liu J; Cao P; Li J; Liu X; Fan X; Liu L; Cheng Y; Xiong W; Li J; Bo H; Zhu Y; Yang F; Hu J; Zhou M; Zhou Y; Zou Q; Zhou J; Cao K
Clin Cancer Res; 2018 Jan; 24(2):445-459. PubMed ID: 29084921
[No Abstract] [Full Text] [Related]
13. Dual role of TGFBR3 in bladder cancer.
Liu XL; Xiao K; Xue B; Yang D; Lei Z; Shan Y; Zhang HT
Oncol Rep; 2013 Sep; 30(3):1301-8. PubMed ID: 23835618
[TBL] [Abstract][Full Text] [Related]
14. Grainyhead-Like 3 Influences Migration and Invasion of Urothelial Carcinoma Cells.
Wezel F; Lustig J; Azoitei A; Liu J; Meessen S; Najjar G; Zehe V; Faustmann P; Zengerling F; John A; Martini T; Bolenz C; Günes C
Int J Mol Sci; 2021 Mar; 22(6):. PubMed ID: 33803949
[TBL] [Abstract][Full Text] [Related]
15. The Role of HMGB1 in Radioresistance of Bladder Cancer.
Shrivastava S; Mansure JJ; Almajed W; Cury F; Ferbeyre G; Popovic M; Seuntjens J; Kassouf W
Mol Cancer Ther; 2016 Mar; 15(3):471-9. PubMed ID: 26719575
[TBL] [Abstract][Full Text] [Related]
16. Interference with HMGB1 increases the sensitivity to chemotherapy drugs by inhibiting HMGB1-mediated cell autophagy and inducing cell apoptosis.
Zhang R; Li Y; Wang Z; Chen L; Dong X; Nie X
Tumour Biol; 2015 Nov; 36(11):8585-92. PubMed ID: 26040768
[TBL] [Abstract][Full Text] [Related]
17. Targeting HMGB1 inhibits ovarian cancer growth and metastasis by lentivirus-mediated RNA interference.
Chen J; Liu X; Zhang J; Zhao Y
J Cell Physiol; 2012 Nov; 227(11):3629-38. PubMed ID: 22331597
[TBL] [Abstract][Full Text] [Related]
18. Long non-coding RNA NEAT1 promotes bladder progression through regulating miR-410 mediated HMGB1.
Shan G; Tang T; Xia Y; Qian HJ
Biomed Pharmacother; 2020 Jan; 121():109248. PubMed ID: 31734579
[TBL] [Abstract][Full Text] [Related]
19. Radiosensitization of esophageal carcinoma cells by knockdown of HMGB1 expression.
Zhang X; Yang X; Zhu S; Li Q; Zou N
Oncol Rep; 2019 Mar; 41(3):1960-1970. PubMed ID: 30569171
[TBL] [Abstract][Full Text] [Related]
20. Importin-11 overexpression promotes the migration, invasion, and progression of bladder cancer associated with the deregulation of CDKN1A and THBS1.
Zhao J; Shi L; Zeng S; Ma C; Xu W; Zhang Z; Liu Q; Zhang P; Sun Y; Xu C
Urol Oncol; 2018 Jun; 36(6):311.e1-311.e13. PubMed ID: 29602637
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
